Director Katabi Reports a $5 Million VERA Purchase

February 1, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a series of Form 4 filings by Maha Katabi, director of Vera Therapeutics $VERA.

Katabi reported a purchase of 161,290 VERA shares, equivalent to $5 million.

Venrock Healthcare Capital Partners revealed the purchase of 88,099 shares of KalVista Pharmaceuticals $KALV in its latest Form 4.

Here’s The Hot Corner, with data through February 1, 2024:

And Cleveland-Cliffs Inc. $CLF director Ron Bloom has bought 25,000 more shares to enhance his ownership position in the business.

Have a great weekend. We’ll be back on Monday with more insider activity.

Filed Under: